Researchers discovered what may be a new approach for creating neuropsychiatric drugs, using a virtual library of compounds derived from chemistry developed by a Yale laboratory.
The new drug candidates they’ve identified through this process could lead...
A new study by investigators at the Yale Center for Outcomes Research and Evaluation (CORE) and Harvard shows the Omicron variant of the COVID-19 virus caused more excess deaths in just eight weeks than the Delta variant caused in its entire 23-week...
In a new study, Yale researchers take a unique approach to identify the molecular signals that induce a critical trigger for hair follicle formation and regeneration.
The findings could prove crucial for developing new therapies to re-grow hair — and...
A new study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug.
The study is based on Phase 3 clinical trials using baricitinib, a Janus kinase (JAK) inhibitor, to treat...
Two Yale faculty members, Donald Engelman and Debra Fischer, have been named fellows of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society.
Engelman is the Eugene Higgins Professor of Molecular...